These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24946246)

  • 1. Psychiatric disorder in essential dyspepsia.
    Kumar S; Khannar R; Hajra B; Bose J
    Int J Psychiatry Clin Pract; 1998; 2(1):41-5. PubMed ID: 24946246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequency of the psychiatric symptoms in the patients with dyspepsia at a university hospital.
    Guz H; Sunter AT; Bektas A; Doganay Z
    Gen Hosp Psychiatry; 2008; 30(3):252-6. PubMed ID: 18433657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyspepsia is strongly associated with major depression and generalised anxiety disorder - a community study.
    Mak AD; Wu JC; Chan Y; Chan FK; Sung JJ; Lee S
    Aliment Pharmacol Ther; 2012 Oct; 36(8):800-10. PubMed ID: 22957985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy in the treatment of depressive and anxiety disorders during a one-year follow-up.
    Maljanen T; Paltta P; Harkanen T; Virtala E; Lindfors O; Laaksonen MA; Knekt P;
    J Ment Health Policy Econ; 2012 Mar; 15(1):13-23. PubMed ID: 22611089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
    Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
    Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients].
    Chabrol H; Chouicha K; Montovany A; Callahan S
    Encephale; 2001; 27(2):120-7. PubMed ID: 11407263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Depressive symptomatology and sleep apnea syndrome].
    Pochat MD; Ferber C; Lemoine P
    Encephale; 1993; 19(6):601-7. PubMed ID: 12404778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
    Brown C; Schulberg HC; Shear MK
    Anxiety; 1996; 2(5):210-8. PubMed ID: 9160625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prevalence of generalized anxiety disorder and comorbidity among psychiatric outpatients].
    Ozcan M; Uğuz F; Cilli AS
    Turk Psikiyatri Derg; 2006; 17(4):276-85. PubMed ID: 17183444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [FAMOTIDINE VERSUS PLACEBO IN NON ULCER DYSPEPSIA TREATMENT].
    Cahuayme L; Berríos J; Recavarren S; Huerta Mercado J; Bussalleu A
    Rev Gastroenterol Peru; 2000; 20(3):213-228. PubMed ID: 12140583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT; Clary CM
    Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.
    Vieta E; Sánchez-Moreno J; Lahuerta J; Zaragoza S;
    J Affect Disord; 2008 Apr; 107(1-3):169-74. PubMed ID: 17870184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of depressive disorder among the permanent sterilized women.
    Khanam M; Mullich MS; Munib AA
    Bangladesh Med Res Counc Bull; 1993 Aug; 19(2):45-51. PubMed ID: 8161334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.
    Lueboonthavatchai P
    J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.